Modulation of host osseointegration during bone regeneration by controlling exogenous stem cell differentiation using a material approach
- 23 October 2013
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 2 (2) , 242-251
Abstract
Stem cell-based tissue engineering for large bone defect healing has attracted enormous attention in regenerative medicine. However, sufficient osseointegration of the grafts combined with exogenous stem cells still remains a major challenge. Here, we developed a material approach to modulate the integration of the grafts to the host tissue when exogenous bone marrow stromal cells (BMSCs) were used as donor cells. Distinctive osseointegration of bone grafts was observed as we varied the content of hydroxyapatite (HA) in the tissue scaffolds implanted in a mouse femur model. More than 80% of new bone was formed in the first two weeks of implantation in high HA content scaffolds but host integration was poor, while only less than 5% of the new bone was formed during this time period in the No HA group but the host integration was good. Cell origin analysis leveraging the GFP reporter indicates new bone in the HA containing groups was mainly derived from donor BMSCs. In comparison, both host and donor cells were found on the new bone surface in the No HA groups which led to seamless bridging between host tissue and the scaffold. Most importantly, host integration during bone formation is closely dictated by the content of HA present in the scaffolds. Taken together, we demonstrate a material approach to modulate the osseointegration of bone grafts in the context of an exogenous stem cell-based bone healing strategy which might lead to fully functional bone tissue regeneration.Keywords
This publication has 48 references indexed in Scilit:
- Controlling the structural organization of regenerated bone by tailoring tissue engineering scaffold architectureJournal of Materials Chemistry, 2012
- Controllable mineral coatings on PCL scaffolds as carriers for growth factor releaseBiomaterials, 2012
- Osteoinductive ceramics as a synthetic alternative to autologous bone graftingProceedings of the National Academy of Sciences, 2010
- Engineered mesenchymal stem cells with self-assembled vesicles for systemic cell targetingBiomaterials, 2010
- Bone tissue engineering with human stem cellsStem Cell Research & Therapy, 2010
- Human stem cell delivery for treatment of large segmental bone defectsProceedings of the National Academy of Sciences, 2010
- The development of tissue-engineered bone of different origin through endochondral and intramembranous ossification following the implantation of mesenchymal stem cells and osteoblasts in a murine modelBiomaterials, 2010
- Induced Pluripotent Stem Cell Lines Derived from Human Somatic CellsScience, 2007
- Projections of Primary and Revision Hip and Knee Arthroplasty in the United States from 2005 to 2030Journal of Bone and Joint Surgery, 2007
- Adipose-derived adult stromal cells heal critical-size mouse calvarial defectsNature Biotechnology, 2004